ASRT Key Statistics, Chart & Performance
The current stock price of ASRT is 9.14 USD. In the past month the price decreased by -21.86%. In the past year, price decreased by -31.11%.
ASRT Latest News, Press Relases and Analysis
ASRT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 49.13 | 1.02T | ||
| JNJ | JOHNSON & JOHNSON | 19.98 | 499.57B | ||
| MRK | MERCK & CO. INC. | 12.08 | 264.21B | ||
| PFE | PFIZER INC | 7.87 | 143.17B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.15 | 108.83B | ||
| ZTS | ZOETIS INC | 19.86 | 55.49B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.45 | 22.43B | ||
| VTRS | VIATRIS INC | 5.35 | 14.35B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.46 | 11.19B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.01B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.56B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 4.43B |
Related stock screener links
About ASRT
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 58 full-time employees. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Company Info
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045 US
CEO: Daniel A. Peisert
Employees: 58
Phone: 12244197106
ASSERTIO HOLDINGS INC / ASRT FAQ
Can you describe the business of ASSERTIO HOLDINGS INC?
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 58 full-time employees. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
What is the stock price of ASSERTIO HOLDINGS INC today?
The current stock price of ASRT is 9.14 USD. The price increased by 0.77% in the last trading session.
Does ASRT stock pay dividends?
ASRT does not pay a dividend.
What is the ChartMill rating of ASSERTIO HOLDINGS INC stock?
ASRT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for ASSERTIO HOLDINGS INC?
ASSERTIO HOLDINGS INC (ASRT) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the PE ratio for ASRT stock?
ASSERTIO HOLDINGS INC (ASRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3).
What is ASSERTIO HOLDINGS INC worth?
ASSERTIO HOLDINGS INC (ASRT) has a market capitalization of 879.73M USD. This makes ASRT a Small Cap stock.
ASRT Technical Analysis
ASRT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ASRT. ASRT has a bad profitability rating. Also its financial health evaluation is rather negative.
ASRT Financial Highlights
Over the last trailing twelve months ASRT reported a non-GAAP Earnings per Share(EPS) of -3. The EPS increased by 72.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.9% | ||
| ROE | -26.89% | ||
| Debt/Equity | 0.37 |
ASRT Forecast & Estimates
For the next year, analysts expect an EPS growth of 87.51% and a revenue growth -9.11% for ASRT